Capula Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,400
Closed -$290K 777
2026
Q1
$290K Buy
3,400
+1,900
+127% +$169K ﹤0.01% 657
2025
Q4
$119K Sell
1,500
-1,100
-42% -$86.2K ﹤0.01% 688
2025
Q3
$208K Buy
2,600
+900
+53% +$76.8K ﹤0.01% 601
2025
Q2
$155K Sell
1,700
-2,600
-60% -$237K ﹤0.01% 430
2025
Q1
$403K Buy
+4,300
New +$385K ﹤0.01% 335
2021
Q4
Sell
-189,500
Closed -$14.2M 293
2021
Q3
$14.2M Buy
189,500
+168,200
+790% +$13.4M 0.18% 103
2021
Q2
$1.72M Buy
+21,300
New +$1.74M 0.03% 312
2020
Q2
Sell
-30,000
Closed -$1.99M 327
2020
Q1
$1.99M Hold
30,000
0.07% 256
2019
Q4
$2.06M Buy
+30,000
New +$2.05M 0.04% 252

Other funds holding CL

Capula Management's CL Position: Q2 2026 in Review

Capula Management sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 243 shares — an estimated $20.7K sold.

Capula Management first reported a position in CL in Q4 2019 and held it in 10 quarters. The position peaked at $4.6M in Q3 2021. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Capula Management reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Capula Management sold 243 Colgate-Palmolive shares in Q2 2026, an estimated $20.7K.
  • Capula Management first reported a position in Colgate-Palmolive in Q4 2019 and held it in 10 quarters.
  • Capula Management's Colgate-Palmolive position peaked at $4.6M in Q3 2021.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.